A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198
Status:
Completed
Trial end date:
2020-10-08
Target enrollment:
Participant gender:
Summary
To investigate safety and tolerability of BI 764198 in healthy male subjects following oral
administration of multiple rising doses per day over 14 days and to explore the
pharmacokinetics (PK) of BI 764198 after single and multiple oral dosing. In addition, the
effect of BI 764198 on the pharmacokinetics of midazolam, given as an oral microdose, will be
explored after multiple oral dosing.